NORTHERN TRUST CORP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,053,283
-0.1%
1,022,605
+12.6%
0.00%
Q2 2023$1,053,945
-29.1%
908,573
-7.6%
0.00%
Q1 2023$1,485,481
-38.2%
983,762
+2.3%
0.00%
-100.0%
Q4 2022$2,403,225
-41.9%
961,290
-1.9%
0.00%0.0%
Q3 2022$4,134,000
+55.1%
979,570
+2.5%
0.00%0.0%
Q2 2022$2,666,000
-49.1%
955,461
+4.4%
0.00%0.0%
Q1 2022$5,237,000
-40.4%
915,569
-4.8%
0.00%0.0%
Q4 2021$8,780,000
-15.0%
961,690
-0.5%
0.00%
-50.0%
Q3 2021$10,335,000
-30.8%
966,657
+0.5%
0.00%
-33.3%
Q2 2021$14,930,000
-3.8%
961,953
+0.5%
0.00%0.0%
Q1 2021$15,513,000
-26.7%
957,017
-4.2%
0.00%
-25.0%
Q4 2020$21,151,000
+39.6%
999,360
-2.2%
0.00%
+33.3%
Q3 2020$15,150,000
-4.7%
1,022,275
-5.4%
0.00%
-25.0%
Q2 2020$15,894,000
+34.5%
1,080,537
+7.3%
0.00%
+33.3%
Q1 2020$11,819,000
-49.4%
1,006,642
+1.3%
0.00%
-40.0%
Q4 2019$23,343,000
+38.1%
993,352
+8.7%
0.01%
+25.0%
Q3 2019$16,902,000
+6.8%
913,621
+7.4%
0.00%0.0%
Q2 2019$15,820,000
-23.0%
851,035
+1.2%
0.00%
-20.0%
Q1 2019$20,556,000
-5.3%
841,072
+0.5%
0.01%
-16.7%
Q4 2018$21,701,000
-18.6%
836,535
-0.8%
0.01%
-14.3%
Q3 2018$26,676,000
-9.9%
842,900
+10.6%
0.01%
-12.5%
Q2 2018$29,616,000
+70.8%
762,315
+21.4%
0.01%
+60.0%
Q1 2018$17,335,000
+76.4%
628,068
+15.7%
0.01%
+150.0%
Q4 2017$9,827,000
+14.1%
542,959
+1.8%
0.00%0.0%
Q3 2017$8,614,000
+11.8%
533,464
-4.1%
0.00%0.0%
Q2 2017$7,706,000
+1.5%
556,407
+10.0%
0.00%0.0%
Q1 2017$7,591,000
+58.0%
506,053
+38.0%
0.00%
+100.0%
Q4 2016$4,803,000
-22.2%
366,685
+2.4%
0.00%
-50.0%
Q3 2016$6,173,000
-4.2%
358,265
+0.4%
0.00%0.0%
Q2 2016$6,443,000
-0.7%
356,979
+4.5%
0.00%0.0%
Q1 2016$6,487,000
-29.0%
341,584
-0.2%
0.00%
-33.3%
Q4 2015$9,143,000
+14.6%
342,416
+4.7%
0.00%0.0%
Q3 2015$7,979,000
-5.9%
327,008
+20.1%
0.00%0.0%
Q2 2015$8,481,000
+122.6%
272,178
+4.0%
0.00%
+200.0%
Q1 2015$3,810,000
+46.4%
261,833
+1.2%
0.00%0.0%
Q4 2014$2,602,000
+33.4%
258,683
+10.5%
0.00%0.0%
Q3 2014$1,950,000
+235.6%
234,079
+396.9%
0.00%
Q2 2014$581,000
+95.0%
47,107
+119.6%
0.00%
Q1 2014$298,00021,4530.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders